- 专利标题： TARGETING SELECT LIPID SIGNALING TO COUNTER TYPE 1 DIABETES (T1D)
-
申请号： US18634143申请日： 2024-04-12
-
公开(公告)号： US20240342196A1公开(公告)日： 2024-10-17
- 发明人: Sansanka Ramanadham , Tayleur D. White , Bruce Hammock , Sung Hee Hwang
- 申请人： The UAB Research Foundation , The Regents of the University of California
- 申请人地址： US AL Birmingham
- 专利权人： The UAB Research Foundation,The Regents of the University of California
- 当前专利权人： The UAB Research Foundation,The Regents of the University of California
- 当前专利权人地址： US AL Birmingham
- 主分类号： A61K31/64
- IPC分类号： A61K31/64 ; A61K31/202 ; A61K31/4468 ; A61P3/10
摘要：
Disclosed herein are lipid signaling pathways that can be targeted to prevent or delay the onset of type 1 diabetes (T1D). In particular, disclosed herein a pathway that can be modulated by a chemical inhibitor. Utilizing this inhibitor, evidence was generated suggesting that it is beneficial in reducing the incidence of T1D.
信息查询
